Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- Check5 days agoChange DetectedRevision history shows a new entry for version v3.3.4 and removal of v3.3.3, indicating an administrative update to the page's history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a Revision: v3.3.3 notice and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 notes from the footer.SummaryDifference0.2%

- Check49 days agoChange DetectedA new revision (v3.3.2) was added to the history. It includes the last known status (Verified, Unknown status) and sponsor location Tianjin Medical University Cancer Institute and Hospital as of 2022-11.SummaryDifference1%

- Check56 days agoChange DetectedA new revision entry v3.3.1 was added to the record history, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe government funding notice banner on the page has been removed, and no study content or functionality changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check77 days agoChange DetectedThe page history screenshots show only non-substantive UI updates and unchanged study information; no modifications to trial title, NCT number, conditions, or enrollment data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.